Publikationen
| 1. | Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation. Kokkiripati PK, Bhakshu LM, Marri S, Padmasree K, Row AT, Raghavendra AS, Tetali SD
J Ethnopharmacol. 2011 Sep;137(1):893-901.
|
| 2. | Olibanum extract inhibits vascular smooth muscle cell migration and proliferation in response to platelet-derived growth factor. Choi OB, Park JH, Lee YJ, Lee CK, Won KJ, Kim J, Lee HM, Kim B
Korean J Physiol Pharmacol. 2009 Apr;13(2):107-13.
|
| 3. | Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M
Cancer Res. 2009 Jul;69(14):5893-900.
|
| 4. | Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis. Hussain S, Slevin M, Ahmed N, West D, Choudhary MI, Naz H, Gaffney J
BMC Cell Biol. 2009;10(0):30.
|
| 5. | BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Tripathi YB
Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):49-57.
|
| 6. | Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration. Popovic M, Laumonnier Y, Burysek L, Syrovets T, Simmet T
J Leukoc Biol. 2008 Jul;84(1):215-23.
|
| 7. | Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice. Cuaz-Pérolin C, Billiet L, Baugé E, Copin C, Scott-Algara D, Genze F, Büchele B, Syrovets T, Simmet T, Rouis M
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):272-7.
|
| 8. | Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid. Poeckel D, Tausch L, Altmann A, Feisst C, Klinkhardt U, Graff J, Harder S, Werz O
Br J Pharmacol. 2005 Oct;146(4):514-24.
|
| 9. | Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis. Tripathi YB, Reddy MM, Pandey RS, Subhashini J, Tiwari OP, Singh BK, Reddanna P
Inflammopharmacology. 2004;12(2):131-52.
|


